B cell receptor signal strength determines B cell fate

Nature Immunology

Volumn 5, Issue 3, 2004, Pages 317-327

  Casola, Stefano ^a,b   Otipoby, Kevin L ^a   Alimzhanov, Marat ^a   Humme, Sibille ^b,c   Uyttersprot, Nathalie ^b,d   Kutok, Jeffrey L ^c   Carroll, Michael C ^a   Rajewsky, Klaus ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; PROTEIN LMP2A; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS PROTEIN; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; LYMPHOCYTE ANTIGEN RECEPTOR; MATRIX PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL FATE; CELL MATURATION; CONTROLLED STUDY; DATA ANALYSIS; EPSTEIN BARR VIRUS; FEMALE; GERMINAL CENTER; INTESTINE LYMPHATIC TISSUE; LYMPH FOLLICLE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DIGESTIVE SYSTEM; GENE TARGETING; GENETICS; HISTOLOGY; IMMUNOLOGY; METABOLISM; PEYER PATCH; PHYSIOLOGY; STEM CELL; TRANSGENIC MOUSE;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; DIGESTIVE SYSTEM; FEMALE; GENE TARGETING; GERMINAL CENTER; MALE; MICE; MICE, TRANSGENIC; PEYER'S PATCHES; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; STEM CELLS; VIRAL MATRIX PROTEINS;

EID: 1542377328     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1036     Document Type: Article

References (59)

1. Berland, R. & Wortis, H.H. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20, 253-300 (2002).
2. Rajewsky, K. Clonal selection and learning in the antibody system. Nature 381, 751-758 (1996).
3. Martin, F. & Kearney, J.F. Marginal-zone B cells. Nat. Rev. Immunol. 2, 323-335 (2002).
4. Hao, Z. & Rajewsky, K. Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J. Exp. Med. 194, 1151-1164 (2001).
5. Schamel, W.W. & Reth, M. Monomeric and oligomeric complexes of the B cell antigen receptor. Immunity 13, 5-14 (2000).
6. Lalor, P.A. & Morahan, G. The peritoneal Ly-1 (CD5) B cell repertoire is unique among murine B cell repertoires. Eur. J. Immunol. 20, 485-492 (1990).
7. Hayakawa, K. et al. Positive selection of natural autoreactive B cells. Science 285, 113-116 (1999).
8. Cariappa, A. & Pillai, S. Antigen-dependent B-cell development. Curr. Opin. Immunol. 14, 241-249 (2002).
9. Bannish, G., Fuentes-Panana, E.M., Cambier, J.C., Pear, W.S. & Monroe, J.G. Ligand-independent signaling functions for the B lymphocyte antigen receptor and their role in positive selection during B lymphopoiesis. J. Exp. Med. 194, 1583-1596 (2001).
10. Chen, X., Martin, F., Forbush, K.A., Perlmutter, R.M. & Kearney, J.F. Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int. Immunol. 9, 27-41 (1997).
11. MacLennan, I.C. Germinal centers. Annu. Rev. Immunol. 12, 117-139 (1994).
12. Muramatsu, M. et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553-563 (2000).
13. Lam, K.P. & Rajewsky, K. B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J. Exp. Med. 190, 471-477 (1999).
14. Watanabe, N. et al. Expression levels of B cell surface immunoglobulin regulate efficiency of allelic exclusion and size of autoreactive B-1 cell compartment. J. Exp. Med. 190, 461-469 (1999).
15. Kraus, M. et al. Interference with immunoglobulin (Ig)α immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B cell development, depending on the availability of an Igβ cytoplasmic tail. J. Exp. Med. 194, 455-469 (2001).
16. Caldwell, R.G., Wilson, J.B., Anderson, S.J. & Longnecker, R. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9, 405-411 (1998).
17. Dykstra, M.L., Longnecker, R. & Pierce, S.K. Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR. Immunity 14, 57-67 (2001).
18. Engels, N. et al. Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module. J. Exp. Med. 194, 255-264 (2001).
19. Miller, C.L. et al. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2, 155-166 (1995).
20. Fruehling, S. & Longnecker, R. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235, 241-251 (1997).
21. Donis-Hernandez, F.R., Parkhouse, R.M. & Santos-Argumedo, L. Ontogeny, distribution and function of CD38-expressing B lymphocytes in mice. Eur. J. Immunol. 31, 1261-1267 (2001).
22. Fruehling, S., Swart, R., Dolwick, K.M., Kremmer, E. & Longnecker, R. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency. J. Virol. 72, 7796-7806 (1998).
23. Cebra, J.J., Logan, A.C. & Weinstein, P.D. The preference for switching to expression of the IgA isotype of antibody exhibited by B lymphocytes in Peyer's patches is likely due to intrinsic properties of their microenvironment. Immunol. Res. 10, 393-395 (1991).
24. Carroll, M.C. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16, 545-568 (1998).
25. Goodnow, C.C. et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334, 676-682 (1988).
26. Pelanda, R. et al. Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell tolerance and antibody diversification. Immunity 7, 765-775 (1997).
27. Lam, K.P., Kuhn, R. & Rajewsky, K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90, 1073-1083 (1997).
28. Merchant, M., Caldwell, R.G. & Longnecker, R. The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo. J. Virol. 74, 9115-9124 (2000).
29. Herzenberg, L.A. B-1 cells: the lineage question revisited. Immunol. Rev 175, 9-22 (2000).
30. Clarke, S.H. & Arnold, L.W. B-1 cell development: evidence for an uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation. J. Exp. Med. 187, 1325-1334 (1998).
31. Hayakawa, K. et al. Positive selection of anti-thy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development. J. Exp. Med. 197, 87-99 (2003).
32. Balazs, M., Martin, F., Zhou, T. & Kearney, J. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17, 341-352 (2002).
33. Schneider, P. et al. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J. Exp. Med. 194, 1691-1697 (2001).
34. Girkontaite, I. et al. Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat. Immunol. 2, 855-862 (2001).
35. Guinamard, R., Okigaki, M., Schlessinger, J. & Ravetch, J.V. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immunol. 1, 31-36 (2000).
36. Lu, T.T. & Cyster, J.G. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 297, 409-412 (2002).
37. Saito, T. et al. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity 18, 675-685 (2003).
38. Ikeda, A., Caldwell, R.G., Longnecker, R. & Ikeda, M. Itchy, a Nedd4 ubiquitin ligase, downregulates latent membrane protein 2A activity in B-cell signaling. J. Virol. 77, 5529-5534 (2003).
39. Portis, T. & Longnecker, R. Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development. J. Virol. 77, 105-114 (2003).
40. Sato, S., Steeber, D.A. & Tedder, T.F. The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc. Natl. Acad. Sci. USA 92, 11558-11562 (1995).
41. Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745 (2000).
42. Hoshino, K. et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162, 3749-3752 (1999).
43. Walport, M.J. Complement. First of two parts. N. Engl. J. Med. 344, 1058-1066 (2001).
44. Neutra, M.R., Mantis, N.J: & Kraehenbuhl, J.P. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat. Immunol. 2, 1004-1009 (2001).
45. Rescigno, M., Rotta, G., Valzasina, B. & Ricciardi-Castagnoli, P. Dendritic cells shuttle microbes across gut epithelial monolayers. Immunobiology 204, 572-581 (2001).
46. Koni, P.A. & Flavell, R.A. Lymph node germinal centers form in the absence of follicular dendritic cell networks. J. Exp. Med. 189, 855-864 (1999).
47. Lanning, D., Zhu, X., Zhai, S.K. & Knight, K.L. Development of the antibody repertoire in rabbit: gut-associated lymphoid tissue, microbes, and selection. Immunol. Rev. 175, 214-228 (2000).
48. Reynaud, C.A., Anquez, V., Grimal, H. & Weill, J.C. A hyperconversion mechanism generates the chicken light chain preimmune repertoire. Cell 48, 379-388 (1987).
49. Reynaud, C.A., Mackay, C.R., Muller, R.G. & Weill, J.C. Somatic generation of diversity in a mammalian primary lymphoid organ: the sheep ileal Peyer's patches. Cell 64, 995-1005 (1991).
50. Jenne, C.N., Kennedy, L.J., McCullagh, P. & Reynolds, J.D. A new model of sheep Ig diversification: shifting the emphasis toward combinatorial mechanisms and away from hypermutation. J. Immunol. 170, 3739-3750 (2003).
51. Weller, S. et al. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc. Natl. Acad. Sci. USA 98, 1166-1170 (2001).
52. Kueppers, R. & Rajewsky, K. The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease. Annu. Rev. Immunol. 16, 471-493 (1998).
53. Kanzler, H., Kuppers, R., Hansmann, M.L. & Rajewsky, K. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J. Exp. Med. 184, 1495-1505 (1996).
54. Sonoda, E. et al. B cell development under the condition of allelic inclusion. Immunity 6, 225-233 (1997).
55. Sauer, B. Manipulation of transgenes by site-specific recombination: use of Cre recombinase. Methods Enzymol. 225, 890-900 (1993).
56. Schwenk, F., Baron, U. & Rajewsky, K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23, 5080-5081 (1995).
57. Wessels, M.R. et al. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA 92, 11490-11494 (1995).
58. Pelanda, R., Schaal, S., Torres, R.M. & Rajewsky, K. A prematurely expressed Igκ transgene, but not VκJκ gene segment targeted into the Igκ locus, can rescue B cell development in λ5-deficient mice. Immunity 5, 229-239 (1996).
59. Birkenbach, M., Josefsen, K., Yalamanchili, R., Lenoir, G. & Kieff, E. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J. Virol. 67, 2209-2220 (1993).